Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui Tan

Showing results (1031-1040 of 1,053) with videos related to

Pageof 106
Sort By:
Cancer Treatment and Research Communications|March 29, 2026
Gain of chromosome 1q and MYCN characterize unique subgroups of Asian Wilms tumor patientsMeng Kang Wong, Kia Teng Lim, Đỗ Thị Ngọc Thùy, et al.
The American Journal of Hospice & Palliative Care|August 21, 2020
Impact of Caring for Terminally Ill Children on Physicians: A Systematic Scoping ReviewLisa Xin Ling Ngiam, Yun Ting Ong, Jun Xuan Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" TrialWei Peng Yong, Sun Young Rha, Iain Bee-Huat Tan, et al.
Emerging Infectious Diseases|June 17, 2015
Severe Pediatric Adenovirus 7 Disease in Singapore Linked to Recent Outbreaks across AsiaOon-Tek Ng, Koh Cheng Thoon, Hui Ying Chua, et al.
Cardiovascular Diabetology|August 31, 2023
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and AsiaDorte Vistisen, Bendix Carstensen, Patorno Elisabetta, et al.
Diabetes & Metabolism|January 7, 2023
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) studyAvraham Karasik, Stefanie Lanzinger, Elise Chia-Hui Tan, et al.
Annals of the Academy of Medicine, Singapore|July 1, 2021
Predictors and outcomes of high-flow nasal cannula failure following extubation: A multicentre observational studyAmit Kansal, Shekhar Dhanvijay, Andrew Li, et al.
Frontiers in Neurology|November 26, 2025
Comparison of endovascular therapy care and outcome in primary and comprehensive stroke centers for acute ischemic stroke in China a real-world nationwide registryTing-Yu Yi, Shujuan Gan, Meihua Wu, et al.
BMC Medical Education|May 11, 2022
Mentoring in palliative medicine in the time of covid-19: a systematic scoping review : Mentoring programs during COVID-19Sherill Goh, Ruth Si Man Wong, Elaine Li Ying Quah, et al.
Cell Reports. Medicine|December 5, 2024
Interpretable multi-modal artificial intelligence model for predicting gastric cancer response to neoadjuvant chemotherapyPeng Gao, Qiong Xiao, Hui Tan, et al.
Pageof 106

Showing results (1031-1040 of 1,053) with videos related to

Sort By:
Pageof 106
Cancer Treatment and Research Communications|March 29, 2026
Gain of chromosome 1q and MYCN characterize unique subgroups of Asian Wilms tumor patientsMeng Kang Wong, Kia Teng Lim, Đỗ Thị Ngọc Thùy, et al.
The American Journal of Hospice & Palliative Care|August 21, 2020
Impact of Caring for Terminally Ill Children on Physicians: A Systematic Scoping ReviewLisa Xin Ling Ngiam, Yun Ting Ong, Jun Xuan Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" TrialWei Peng Yong, Sun Young Rha, Iain Bee-Huat Tan, et al.
Emerging Infectious Diseases|June 17, 2015
Severe Pediatric Adenovirus 7 Disease in Singapore Linked to Recent Outbreaks across AsiaOon-Tek Ng, Koh Cheng Thoon, Hui Ying Chua, et al.
Cardiovascular Diabetology|August 31, 2023
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and AsiaDorte Vistisen, Bendix Carstensen, Patorno Elisabetta, et al.
Diabetes & Metabolism|January 7, 2023
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) studyAvraham Karasik, Stefanie Lanzinger, Elise Chia-Hui Tan, et al.
Annals of the Academy of Medicine, Singapore|July 1, 2021
Predictors and outcomes of high-flow nasal cannula failure following extubation: A multicentre observational studyAmit Kansal, Shekhar Dhanvijay, Andrew Li, et al.
Frontiers in Neurology|November 26, 2025
Comparison of endovascular therapy care and outcome in primary and comprehensive stroke centers for acute ischemic stroke in China a real-world nationwide registryTing-Yu Yi, Shujuan Gan, Meihua Wu, et al.
BMC Medical Education|May 11, 2022
Mentoring in palliative medicine in the time of covid-19: a systematic scoping review : Mentoring programs during COVID-19Sherill Goh, Ruth Si Man Wong, Elaine Li Ying Quah, et al.
Cell Reports. Medicine|December 5, 2024
Interpretable multi-modal artificial intelligence model for predicting gastric cancer response to neoadjuvant chemotherapyPeng Gao, Qiong Xiao, Hui Tan, et al.
Pageof 106